Sunridge International to Present to the Long Island Investment Banking Group
February 22 2010 - 9:00AM
PR Newswire (US)
FOUNTAIN HILLS, Ariz., Feb. 22 /PRNewswire-FirstCall/ -- Sunridge
International, (OTC:SNDZ) (BULLETIN BOARD: SNDZ) announced that it
will be making a presentation today to the Long Island Investment
Banking Group, comprised of over 73 of the top brokerage firms in
the Long Island area. In its presentation, Sunridge International
(http://www.sunridgeint.com/) intends to communicate progress
achieved in developing its business model as well as the
significant progress made throughout the European market, and to
inform attendees of the abundant market opportunity. Sunridge will
be seeking to increase market awareness, initiate research
coverage, add market makers, and attract both institutional and
retail investors to its publicly traded stock. About LIIBG The
LIIBG was founded in 1996 by brokers to serve brokers and publicly
traded companies. We are the strongest investment banking group in
the tri-state area focusing on small cap/micro cap companies. Our
monthly meeting is well attended by licensed, active brokers
comprising an average of two billion dollars under management.
About Sunridge International Sunridge, through it's wholly owned
subsidiary Ophthalmic International, has developed and patented
Pneumatic Trabeculoplasty, "PNT", a two-minute, non-evasive, cost
effective alternative treatment for Glaucoma and Ocular
Hypertension. Glaucoma is the second leading cause of blindness,
effecting over 70 million people worldwide. PNT has been proven
(through studies completed over the last 10 yrs) to be a safe and
effective treatment with no adverse side effects associated with
it, unlike typical forms of glaucoma treatment. Forward-looking
statements in this release are made pursuant to the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995.
Investors are cautioned that such forward-looking statements
involve risks and uncertainties, including without limitation,
continued acceptance of the company's products, increased levels of
competition for the company, new products and technological
changes, the company's dependence on third-party suppliers, and
other risks detailed from time to time in the company's periodic
reports filed with the Securities and Exchange Commission. Contact:
Jeff Smith (480)837-6165 DATASOURCE: Sunridge International
CONTACT: Jeff Smith, +1-480-837-6165 Web Site:
http://www.sunridgeint.com/
Copyright